Ironwood Pharmaceuticals (IRWD) Total Current Liabilities (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Total Current Liabilities across 17 years of filings, most recently posting $32.9 million for Q2 2026.

• In Q2 2026, Total Current Liabilities fell 85.87% year-over-year to $32.9 million; the TTM figure through Jun 2026 stood at $32.9 million (down 85.87% YoY), while the FY2025 annual figure was $242.2 million, up 523.53% from the prior year.
• Total Current Liabilities came in at $32.9 million for Q2 2026 at Ironwood Pharmaceuticals, down from $236.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $305.4 million in Q2 2023 to a low of $23.3 million in Q2 2022.
• Average Total Current Liabilities over 5 years is $140.6 million, with a median of $98.4 million recorded in 2022.
• Year-over-year, Total Current Liabilities soared 1210.8% in 2023 and sank 85.93% in 2024.
• Over 5 years, Total Current Liabilities stood at $25.5 million in 2022, then surged by 981.69% to $276.1 million in 2023, then slumped by 85.93% to $38.8 million in 2024, then soared by 523.53% to $242.2 million in 2025, then slumped by 86.44% to $32.9 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $32.9 million in Q2 2026, $236.3 million in Q1 2026, and $242.2 million in Q4 2025.